A UCL study found that 70% of young people with long Covid recovered within 24 months, but recovery was less likely among older teenagers, females, and those from deprived backgrounds. Researchers emphasized the need for further investigation and collaboration to address unresolved cases.
A new study led by UCL researchers reveals that most young individuals diagnosed with long Covid three months after a positive PCR test had fully recovered within 24 months.
The Children and young people with Long Covid (CLoCK) study, published in Nature Communications Medicine and funded by the National Institute for Health and Care Research (NIHR), is the world's largest longitudinal cohort study on long Covid in children.
The researchers, led by Professor Sir Terence Stephenson and Professor Roz Shafran (both UCL Great Ormond Street Institute of Child Health), asked young people aged 11 to 17 about their health three, six, 12 and 24 months after taking a PCR test for the Covid virus between September 2020 and March 2021. They also asked them to recall their symptoms at the time of taking the test.
In February 2022, the researchers published a consensus definition of long Covid which involved a young person having more than one symptom (such as tiredness, trouble sleeping, shortness of breath or headaches) alongside problems with either mobility, self-care, doing usual activities, having pain/discomfort, or feeling very worried or sad.
The researchers used this definition for their new study, which examined data from 12,632 young people who had a PCR test for SARS-CoV-2 (the virus that causes COVID-19). They found that around 25-30% of young people met the research definition of long Covid 24 months after their initial PCR test.
Study Results: Recovery Trends
Of the 12,632 young people in total, there were 943 who had tested positive when first approached and who provided answers at every time point: three, six, 12 and 24 months after their original test.
Of these 943 young people, 233 met the research definition of long Covid three months after their initial positive test. At six months,135 continued to meet the research definition of long Covid. At 12 months, 94 continued to fulfill the long Covid research definition.
However, only 68 of these 943 children and young people (7.2%) continued to fulfill the long Covid research definition when contacted 24 months after their initial positive test.
This means that 24 months after a proven Covid infection, 165 of the 233 young people (70%) who had long Covid three months after the infection and provided information at every time point in the research had recovered. But 68 of the 233 (30%) had not.
Key Demographic Findings
Older teenagers and the most deprived were less likely to have recovered. And, strikingly, females were almost twice as likely to still meet the research definition of long Covid at 24 months, compared to males.
However, the researchers note that they did not assess menstruation and some symptoms (such as headaches and tiredness) may be attributable to pre-menstrual syndrome given the high proportion of girls.
Study Chief Investigator and first author, Professor Sir Terence Stephenson, said: "Our findings show that for teenagers who fulfilled our research definition of long Covid three months after a positive test for the Covid virus, the majority have recovered after two years. This is good news but we intend to do further research to try to better understand why 68 teenagers had not recovered."
The CLoCK study is a major study funded by the National Institute for Health and Care Research (NIHR) and UK Research and Innovation (UKRI) to help improve understanding of the causes, symptoms, and treatment of the longer-term effects of Covid-19 in people who have not become unwell enough to be admitted to hospital.
The study was co-led by the UK Health Security Agency (UKHSA) in collaboration with researchers at Great Ormond Street Hospital for Children NHS Foundation Trust (GOSH), Imperial College London, King's College London, Manchester University NHS Foundation Trust, the Universities of Bristol, Cambridge, Edinburgh, Liverpool, Manchester and Oxford, and University College London Hospitals NHS Foundation Trust. CLoCK also works closely with a patient and public involvement advisory group.
Following the 24-month results, data from all time points are now publicly available to other researchers.
The UCL researchers recently published a commentary, alongside colleagues at GOSH and the University of Brighton, on why better collaboration is needed between clinicians, interventionalists, epidemiologists, statisticians and those with lived experience to ensure a more effective, coordinated response ahead of future pandemics.
Study limitations
The symptoms reported by participants at the time of testing are subject to recall bias as they were reported at the time of first contact with the CLoCK study. However, three-month, six-month, 12-month, and 24-month symptoms were reported at the time they were being experienced.
Of the 31,012 children and young people invited to fill in a questionnaire 24-months post-PCR test, 12,632 of them participated and so this is a self-selected group which may introduce bias in the results.
Original PCR tests were taken before the Delta and Omicron variants became dominant, so the findings may not reflect the long-term effects of these variants.
Children and young people self-reported their symptoms. In some instances, such as to assess shortness of breath, it may have been better to conduct in-person medical interviews. However, this was not feasible or practical during the study period.
Importantly, the study primarily focuses on children and young people in England, and the findings may not be directly applicable to other populations or countries with different healthcare systems, vaccination rates, and demographics.
Reference: "A 24-month National Cohort Study examining long-term effects of COVID-19 in children and young people" by Terence Stephenson, Snehal M. Pinto Pereira, Manjula D. Nugawela, Emma Dalrymple, Anthony Harnden, Elizabeth Whittaker, Isobel Heyman, Tamsin Ford, Terry Segal, Trudie Chalder, Shamez N. Ladhani, Kelsey McOwat, Ruth Simmons, Laila Xu, Lana Fox-Smith, CLoCk Consortium and Roz Shafran, 4 December 2024, Communications Medicine.
DOI: 10.1038/s43856-024-00657-x
News
Scientists Discover a Hidden “Immune Organ” Inside the Skull
Researchers discovered lymph node-like immune hubs inside skull bone marrow that appear to act as rapid-response centers for the brain. For decades, the brain was thought to operate largely apart from the immune system. [...]
Engineered tRNAs and lipid nanoparticles target nonsense mutation cystic fibrosis
Researchers have developed a potential new approach for treating a form of cystic fibrosis caused by so-called nonsense mutations, combining chemically modified transfer RNAs with lipid nanoparticles designed to deliver the therapy directly to [...]
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Researchers Have Discovered a New Way To Reduce Chronic Nerve Pain
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Quantum-Enabled Regenerative Health: Reimagining Wellness, Precision Health and Longevity Medicine
Introduction Healthcare is approaching a frontier where the quantum portfolio could influence not only how disease is diagnosed and treated, but how health itself is measured, modeled, predicted and preserved. Quantum computing, quantum simulation, [...]
FDA Clears First-of-Its-Kind Nonmedication Treatment for PTSD
The FDA has cleared a system that uses brain activity data to personalize magnetic stimulation for PTSD, adding a new nonmedication treatment option. Every day in the United States, approximately 17.5 veterans die by suicide, [...]
FDA approves breakthrough drug to treat advanced pancreatic cancer
The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer. The drug, called daraxonrasib, will be sold under the brand name Rasonque [...]
AI Decodes a Hidden DNA Signal Linked to Disease-Causing Mutations
Machine learning identifies the likely “initiator” and enables new predictions about DNA mutations that can cause disease. Every human cell depends on tens of thousands of genes being switched on at the right time [...]
Pope Leo Urges Global Response to Congo’s Deadliest Ebola Outbreak
Pope Leo called for international action to address the Ebola outbreak in the Democratic Republic of Congo. The epidemic has claimed over 2,500 lives and is the nation's largest recorded outbreak. The Pope emphasized [...]
Is there a summer COVID-19 surge this year? Yep, it’s ramping up again
Hantavirus. Ebola. West Nile. Measles. And, of course, cyclospora — that stomach parasite making people miserable across the country. Americans have plenty to worry about this summer. But remember COVID-19? It may not be [...]
Natural Compound in Broccoli Could Help Treat a Rare, Incurable Neurological Disease
Swinburne researchers have discovered how broccoli could help treat an extremely rare and incurable disease that affects only about 200 Australians. A naturally occurring compound in broccoli is being investigated as a possible treatment [...]
Antibody recycling, FcRn and the next generation of biologics
FcRn plays a central role in regulating the half-life of IgG antibodies and albumin, making it a critical target in both antibody engineering and autoimmune disease therapy. This article explores the biology of FcRn, [...]
Ebola kills 2,300 in three months with no vaccine available for Congo’s deadliest ever outbreak
It’s Congo’s 17th outbreak, with a toll that has eclipsed that of the country’s 2018-2020 outbreak when 2,299 deaths out of 3,481 cases were recorded. The latest data shows 101 new cases and 33 [...]
Beyond an Agency: How AI, Creativity and Commercialization Are Converging Into a New Growth Model
At a moment when AI is forcing a fundamental rethink of how work gets done, the life sciences industry is grappling with a deeper question: what role should human creativity play in an increasingly [...]
New $60 Blood Test Detects Lung Cancer Without Costly DNA Sequencing
A simple blood test that detects chemical changes in DNA identified more than 90% of stage 2-4 lung cancers in an early study, without relying on costly DNA sequencing. Researchers at Tel Aviv University and collaborating [...]















